300 ML linezolid 2 MG/ML Injection [Zyvox]
linezolid
RxCUI: 1662286
What the CMS Formulary Data Shows for 300 ML linezolid 2 MG/ML Injection [Zyvox]
Per the CMS 2026 Part D formulary file, 300 ML linezolid 2 MG/ML Injection [Zyvox] (RxNorm concept RXCUI 1662286, generic name linezolid) appears on 2 distinct formulary files spanning 8 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.
Real-world access to 300 ML linezolid 2 MG/ML Injection [Zyvox] depends on utilization management as much as tier placement: 50% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 300 ML linezolid 2 MG/ML Injection [Zyvox] today.
Coverage Details
- Formularies covering
- 2
- Plans covering
- 8
- Coverage rate
- 0.2%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 50% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 300 ML linezolid 2 MG/ML Injection [Zyvox]
8 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
| Óptimo Plus (PPO) | TRIPLE S ADVANTAGE, INC. | T4 | Yes | $0 | PR |
| Contigo Plus (HMO C-SNP) | TRIPLE S ADVANTAGE, INC. | T4 | Yes | $0 | PR |
| Brillante (HMO-POS) | TRIPLE S ADVANTAGE, INC. | T4 | Yes | $0 | PR |
| Enlace Plus (HMO) | TRIPLE S ADVANTAGE, INC. | T4 | Yes | $0 | PR |
| ContigoEnMente (HMO C-SNP) | TRIPLE S ADVANTAGE, INC. | T4 | Yes | $0 | PR |
| Ahorro Plus (HMO) | TRIPLE S ADVANTAGE, INC. | T4 | Yes | $0 | PR |
Frequently Asked Questions
Is 300 ML linezolid 2 MG/ML Injection [Zyvox] covered by Medicare Part D?
Yes, 300 ML linezolid 2 MG/ML Injection [Zyvox] is covered by 8 Medicare Part D plans (0.2% of all Part D formularies).
What tier is 300 ML linezolid 2 MG/ML Injection [Zyvox] on Medicare Part D plans?
300 ML linezolid 2 MG/ML Injection [Zyvox] averages Tier 2.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does 300 ML linezolid 2 MG/ML Injection [Zyvox] require prior authorization?
50% of Part D formularies require prior authorization for 300 ML linezolid 2 MG/ML Injection [Zyvox]. Step therapy: 0%. Quantity limits: 0%.
Read our methodology - how this data is sourced, computed, and verified.